Results 191 to 200 of about 63,781 (241)
Evaluation of ASCA IgA/IgG seropositivity, fecal calprotectin levels and NOD2 gene polymorphisms in patients with hidradenitis suppurativa: A prospective case-control study. [PDF]
Tanrıbilir ME +6 more
europepmc +1 more source
Objective We aimed to test the efficacy of personalized treatment of older veterans with chronic low back pain (CLBP) delivered by Aging Back Clinics (ABCs) as compared with usual care (UC). Methods Two hundred ninety‐nine veterans aged 65 to 89 with CLBP from three Veterans Affairs (VA) medical centers underwent baseline testing, randomization to ABC ...
Debra K. Weiner +9 more
wiley +1 more source
Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis. [PDF]
Villalobos Navarro A +19 more
europepmc +1 more source
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung +7 more
wiley +1 more source
Characterizing the NIH Activity and Chronicity Indices in 2 Independent Lupus Nephritis Cohorts. [PDF]
Querin V +8 more
europepmc +1 more source
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
Histopathological Findings of Appendix Specimens in Quiescent Ulcerative Colitis: Correlations With Clinical Outcomes in the ACCURE Trial. [PDF]
Visser E +6 more
europepmc +1 more source

